Model Number FV046P |
Device Problem
Infusion or Flow Problem (2964)
|
Patient Problem
Hydrocephalus (3272)
|
Event Date 12/02/2020 |
Event Type
Injury
|
Manufacturer Narrative
|
Investigation is still pending, because the product was not received for investigation.A supplemental report was submitted when additional information are provided.
|
|
Event Description
|
It was reported that there was a problem with a ventricular catheter, blockage.Same events were reported as mdr#: 3004721439-2020-00257, 3004721439-2020-00258, 3004721439-2020-0025, 3004721439-2020-00260.Patient information: age: (b)(6) year weight: (b)(6), height: 70 cm, gender: unknown, date of implantation: unknown, date of removal: (b)(6) 2020.
|
|
Manufacturer Narrative
|
Visual inspection in the first step of our investigation, we performed a visual inspection of the product.We have checked for possible damages, deformations of the housing or other abnormalities.The following observations were made during the visual inspection: additional inserted holes could be detected on one catheter.Permeability test to check if the ventricular catheters are blocked, we have performed a permeability test on the product.The test showed that the ventricular catheter were permeable.Internal inspection of product in order to verify whether the investigated ventricular catheter were compromised by the known risks of hydrocephalus therapy, e.G.By a build-up of natural substances (protein, blood, or tissue particles) in the cerebrospinal fluid, we have dismantled the catheters.After dismantling of the catheters, was found in one piece of catheter slightly deposits were found.Results: based on our investigation, we are not able to substantiate the claim of "blockage".However, we assume that the significant deposits found within the product may have temporarily caused the functional impairment.Deposits caused by natural substances in the cerebrospinal fluid, such as protein, blood or tissue particles, are among the known and unavoidable risks and side effects of hydrocephalus therapy.We can exclude a defect at the time of release.The product system met all specifications of the final inspection when released from christoph miethke gmbh & co.Kg.
|
|
Event Description
|
The product was received for investigation on 01/04/2021 same events were reported as mdr#3004721439-2020-00257, 3004721439-2020-00258, 3004721439-2020-0059, 3004721439-2020-00260.
|
|
Search Alerts/Recalls
|
|